Cytokinetics reported $88.97M in Sales Revenues for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acadia Pharmaceuticals ACAD:US $ 134.56M 19.1M
Acorda Therapeutics ACOR:US $ 31.05M 8.52M
Amgen AMGN:US $ 6594M 356M
Bayer BAYN:GR € 12819M 1820M
Biogen BIIB:US $ 2589.1M 57.3M
Bristol Myers Squibb BMY:US $ 11887M 239M
Cytokinetics CYTK:US $ 88.97M 87.82M
Eisai 4523:JP Y 184262M 6639M
Eli Lilly And LLY:US $ 6488M 1322M
Exelixis EXEL:US $ 419.43M 63.45M
Genocea Biosciences GNCA:US $ 0.27M 0.27M
Geron GERN:US $ 0.07M 0.05M
Halozyme Therapeutics HALO:US $ 152.36M 35.09M
Intra Cellular Therapies ITCI:US $ 55.58M 20.58M
IONIS PHARMACEUT IONS:US $ 133.79M 8.13M
Ligand Pharmaceuticals LGND:US $ 83.64M 37.95M
Merk MRK:US $ 14593M 1308M
Novartis NOVN:VX SF 13085M 271M
Pfizer PFE:US $ 27742M 2081M
Regeneron Pharmaceuticals REGN:US $ 2857.2M 107.9M
Roche Holding ROG:VX 16.44B 474M